PEB · Pebblebrook Hotel Trust

Current Thesis

Pebblebrook Hotel Trust’s lodging-recovery thesis requires October 29 results to sustain its raised earnings outlook before the market loses the $16 June breakout shelf. The operating test is third-quarter same-property revenue per available room (RevPAR) growth above the +1% guidance floor, with the full-year earnings range retained. A weekly close below $16 invalidates the price structure independently of that operating test.

The calendar has changed since September 6: the company’s September 11 announcement confirms results after the market closes on 2026-10-29 and a conference call on 2026-10-30, replacing the earlier October 27 estimate. Company announcement

The narrative is maturing — an inference supported by the September 14 snapshot of 16 covering analysts and September 15 coverage revisiting June insider purchases. Those observations establish continuing attention, but the sample is too small to establish saturated ownership or expanding participation. Analyst snapshot, September 15 commentary

Bullish and bearish views on Pebblebrook Hotel Trust

The model's bull view on Pebblebrook Hotel Trust (PEB), in brief: Operating recovery has reported support. The bear view: Management already expects slower growth. Both cases follow in full.

Bull Case

• Operating recovery has reported support. The July 29 release reported second-quarter same-property RevPAR growth of 6.5%, including 16.0% in San Francisco and 12.0% at resorts. These are measured operating results supporting the recovery thesis. Company results
• Raised guidance defines the hurdle. On July 29, management raised full-year adjusted earnings before interest, taxes, depreciation and amortization for real estate (adjusted EBITDAre) guidance to $345–353 million. Retention of that range at the October 29 release is a condition of this thesis. Company results
• A constructive analyst remains engaged. Investing.com reported on September 10 that Truist retained its $22 price target and raised its 2026 adjusted funds from operations forecast to $1.88 per share from $1.82. These are Truist’s estimates, not reported company results. September 10 report

Bear Case

• Management already expects slower growth. July 29 guidance puts third-quarter same-property RevPAR growth at 1%–3%. A result at or below 1% would fail the operating condition specified here. Company outlook
• Next-year estimates moved lower. In the September 10 report, Truist reduced its 2027 adjusted EBITDAre estimate to $373 million from $379 million. The retained $22 analyst target therefore accompanied a lower earnings estimate for the following year. Truist report
• Price momentum lacks confirmation. The September 18 adjusted market snapshot records a three-month price decline of 3.6% and a 14-day relative strength index (RSI) of 44.3. Neither observation establishes renewed upward momentum.

Setup & Price Structure

The September 18 split- and dividend-adjusted close was $18.04, with the supplied market series showing the shares 8.7% below their $19.75 52-week high. The $16 June breakout shelf identified in the September 6 research remains the published structural boundary. The latest close is above it; that observation does not establish that every intervening weekly close held it.

The September 14 analyst snapshot showed a $19.12 average target across 16 analysts and a consensus Hold rating. These figures measure analyst coverage, not ownership concentration. No moving-average distance, short-interest reading or trading-volume series is available to establish crowded positioning. Analyst snapshot

Benzinga’s September 15 article highlighted first-half company repurchases and June purchases by Jon Bortz. Its publication date is fresh; the transactions it discusses are historical. That article alone cannot establish new September insider demand or a retail-attention cluster. September 15 commentary

Catalyst Calendar (next 30 days)

No confirmed thesis-resolving event is identified for 2026-09-20 through 2026-10-20. The company lists a dividend announcement dated September 15, which has already occurred; its upcoming record and payment dates are not verified. Company news listing

• 2026-10-29 — Third-quarter results, after market close. This later event is included because it directly tests the RevPAR condition and retention of full-year guidance. The company confirmed the date on September 11. Earnings schedule
• 2026-10-30 — Earnings conference call. The September 11 announcement schedules management’s discussion for this date; the relevant distinction is between reported third-quarter performance and assumptions supporting the remaining outlook. Call schedule

What Would Change Our Mind

Loss of the June breakout shelf would end the structural case: a weekly close below $16 is the gradeable condition. Separately, third-quarter RevPAR growth at or below +1%, or a cut to the July 29 full-year adjusted EBITDAre range of $345–353 million, would break the operating thesis at the October 29 release.

The positive case is satisfied if that release reports growth above the stated floor and retains or raises the annual range before invalidation occurs. Conviction is moderate: July’s operating evidence supports the case, while September 18 momentum and Truist’s September 10 reduction to its following-year estimate limit confidence.

Correlation Notes

This is a single-company lodging-recovery case; no measured peer or index correlation is supplied. June 30 net debt to trailing corporate EBITDA of 5.3 times identifies financing exposure, but does not establish a numerical relationship between PEB and interest-rate changes. Company balance-sheet discussion